Recap: Coherus BioSciences Q3 Earnings

Coherus BioSciences CHRS reported its Q3 earnings results on Monday, November 8, 2021 at 04:01 PM.

Here's what investors need to know about the announcement.

Earnings

Coherus BioSciences their estimated earnings by 54.55%, reporting an EPS of $-0.34 versus an estimate of $-0.22, which surprised analysts.

Revenue was up $31,048,000 from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.19, which was followed by a 0.46% increase in the share price the next day.

Here's a look at Coherus BioSciences's past performance:

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.